Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centre

Overview of attention for article published in Breast Cancer Research and Treatment, January 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy: 1 policy source

patent: 1 patent

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 26 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

INHIBITORS OF CDK8/19 FOR USE IN TREATING ESTROGEN RECEPTOR POSITIVE BREAST CANCER

Application WO-2014134169-A1

World Intellectual Property Organisation (WIPO)